David M. Goldstein
2019
In 2019, David M. Goldstein earned a total compensation of $2.2M as Chief Scientific Officer at Principia Biopharma.
Compensation breakdown
| Non-Equity Incentive Plan | $240,000 |
|---|---|
| Option Awards | $1,584,798 |
| Salary | $412,000 |
| Other | $1,798 |
| Total | $2,238,596 |
Goldstein received $1.6M in option awards, accounting for 71% of the total pay in 2019.
Goldstein also received $240K in non-equity incentive plan, $412K in salary and $1.8K in other compensation.
Rankings
In 2019, David M. Goldstein's compensation ranked 5,352nd out of 13,971 executives tracked by ExecPay. In other words, Goldstein earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,352 out of 13,971 | 62nd |
Division Manufacturing | 1,997 out of 5,701 | 65th |
Major group Chemicals And Allied Products | 707 out of 2,200 | 68th |
Industry group Drugs | 593 out of 1,886 | 69th |
Industry Pharmaceutical Preparations | 440 out of 1,398 | 69th |
Source: SEC filing on April 24, 2020.
Goldstein's colleagues
We found two more compensation records of executives who worked with David M. Goldstein at Principia Biopharma in 2019.